BSA Icon

4. BIOTECH SUMMIT AUSTRIA 2026

13 – 14 Oct 2026 | Innsbruck, Austria

ServiceUpdated on 13 October 2026

Subcutaneous Drug Delivery & mAb Evaluation

Head of institute HEALTH at Joanneum Research Forschungsges. mbH

Graz, Austria

About

JOANNEUM RESEARCH HEALTH supports developers of subcutaneously (SC) administered therapeutics, including monoclonal Antibodies (mAbs). We provide critical in-vivo data on local absorption, bioavailability, and tissue interaction to optimize SC formulations and accelerate clinical translation.

Core Services & Applications

• Local Pharmacokinetics & Bioavailability: Continuous monitoring of drug deposition, local recovery, and systemic absorption directly from the subcutaneous interstitial fluid using dermal/adipose Open Flow Microperfusion (OFM).

• Large Molecule Capability: OFM’s patented, membrane-free probe design allows for the sampling of large proteins and high-molecular-weight molecules (like mAbs) without clogging or molecular filtering.

• Tissue Compatibility & Tolerability: In-vivo and ex-vivo screening of local injection-site reactions, inflammation biomarkers, and tissue compatibility of high-concentration formulations.

• GLP Bioanalytics for Biologics: High-throughput GLP-compliant quantification of mAbs and biopharmaceuticals in tissue samples and systemic circulation via advanced immunochemistry (MSD, ELISA) and LC-MS/MS.

Organisation

Similar opportunities